Cerebral childhood and adolescent X-linked adrenoleukodystrophy. Clinical presentation, neurophysiological, neuroimaging and biochemical investigations

Folia Neuropathologica

Volumn 44, Issue 4, 2006, Pages 319-326

  Zgorzalewicz Stachowiak, Małgorzata ^a   Stradomska, Teresa Joanna ^b   Bartkowiak, Zuzanna ^a   Galas Zgorzalewicz, Bozena ^c  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^c NONE

Author keywords

Adolescent cerebral form; Adrenoleukodystropy; Childhood cerebral form; Evoked potentials; Magnetic resonance imaging; Very long chain fatty acids

Indexed keywords

LONG CHAIN FATTY ACID;

ADOLESCENT; ADRENAL INSUFFICIENCY; ADRENOLEUKODYSTROPHY; ARTICLE; ATAXIA; BIOCHEMISTRY; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMYELINATION; DISEASE COURSE; EVOKED BRAIN STEM RESPONSE; EVOKED SOMATOSENSORY RESPONSE; EVOKED VISUAL RESPONSE; FATTY ACID BLOOD LEVEL; HEARING IMPAIRMENT; HUMAN; MALE; MENTAL DETERIORATION; NEUROIMAGING; NEUROPHYSIOLOGY; SEIZURE; SPASTICITY; VISUAL IMPAIRMENT; X CHROMOSOME LINKED DISORDER;

EID: 33846143862     PISSN: 16414640     EISSN: 1509572X     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Afifi AK, Menezes AH, Reed LA, Bell WE. Atypical presentation of X-linked childhood adrenoleukodystrophy with an unusual magnetic resonance imaging pattern. J Child Neurol 1996; 11: 497-499.
2. Aubourg P, Sellier N, Chaussain JL, Kalifa G. MRI detects cerebral involvement in neurologically asymptomatic patients with adrenoleukodystrophy. Neurology 1989; 39: 1619-1621.
3. Barkovich AJ, Ferriero DM, Bass N, Boyer R. Involvement of the pontomedullary corticospinal tracts: a useful finding in the diagnosis of X-linked adrenoleukodystrophy. AJNR Am J Neuroradiol 1997 Jan; 18: 95-100.
4. Bekiesinska-Figatowska M, Tylki-Szymanska A, Walecki J, Stradomska TJ. MRI findings in an asymptomatic boy with X-linked adrenoleukodystrophy and his symptomatic mother. Neuroradiology 2001; 43: 951-952.
5. Close PJ, Sinnott SJ, Nolan KT. Adrenoleukodystrophy. A case report demonstrating unilateral abnormalities. Pediatr Radiol 1993; 23: 400-401.
6. Heim P, Claussen M, Hoffmann B, Conzelmann E, Gartner J, Harzer K, Hunneman DH, Kohler W, Kurlemann G, Kohlschutter A. Leukodystrophy incidence in Germany. Am J Med Genet 1997; 71: 475-478.
7. Jensen ME, Sawyer RW, Braun IF, Rizzo WB. MR imaging appearance of childhood adrenoleukodystrophy with auditory, visual, and motor pathway involvement. Radiographics 1990; 10: 53-66.
8. Kirk EP, Fletcher JM, Sharp P, Carey B, Poulos A. X-linked adrenoleukodystrophy: the Australasian experience. Am J Med Genet 1998; 76: 420-423.
9. Korenke GC, Fuchs S, Krasemann E, Doerr HG, Wilichowski E, Hunneman DH, Hanefeld F. Cerebral adrenoleukodystrophy (ALD) in only one of monozygotic twins with an identical ALD genotype. Ann Neurol 1996; 40: 254-257.
10. Korenke GC, Roth C, Krasemann E, Hufner M, Hunneman DH, Hanefeld F. Variability of endocrinological dysfunction in 55 patients with X-linked adrenoleukodystrophy: clinical, laboratory and genetic findings. Eur J Endocrinol 1997; 137: 10-12.
11. Melhem ER, Barker PB, Raymond GV, Moser HW. X-linked adrenoleukodystrophy in children: review of genetic, clinical, and MR imaging characteristics. AJR Am J Roentgenol 1999; 173: 1575-1581.
12. Migeon BR, Moser HW, Moser AB, Axelman J, Sillence D, Norum RA. Adrenoleukodystrophy: evidence for X-linkage, inactivation, and selection favoring the mutant allele in heterozygous cells. Proc Natl Acad Sci USA 1981; 78: 5066-5070.
13. Moser HW. Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy. Brain 1997; 120: 1485-1508.
14. Restuccia D, Di Lazzaro V, Valeriani M, Oliviero A, Le Pera D, Colosimo C, Burdi N, Cappa M, Bertini E, Di Biase A, Tonali P. Neurophysiological abnormalities in adrenoleukodystrophy carriers. Evidence of different degrees of central nervous system involvement. Brain 1997; 120: 1139-1148.
15. Riva D, Bova SM, Bruzzone MG. Neuropsychological testing may predict early progression of asymptomatic adrenoleukodystrophy. Neurology 2000; 54: 1651-1655.
16. Ronghe MD, Barton J, Jardine PE, Crowne EC, Webster MH, Armitage M, Allen JT, Steward CG. The importance of testing for adrenoleukodystrophy in males with idiopathic Addison's disease. Arch Dis Child 2002; 86: 185-189.
17. Ruiz M, Coll MJ, Pampols T, Giros M. X-linked adrenoleukodystrophy: phenotype distribution and expression of ALDP in Spanish kindreds. Am J Med Genet 1998; 76: 415-419.
18. Schmidt S, Traber F, Block W, Keller E, Pohl C, von Oertzen J, Schild H, Schlegel U, Klockgether T. Phenotype assignment in symptomatic female carriers of X-linked adrenoleukodystrophy. J Neurol 2001; 248: 36-44.
19. Sereni C, Paturneau-Jouas M, Aubourg P, Baumann N, Feingold J. Adrenoleukodystrophy in France: an epidemiological study. Neuroepidemiology 1993; 12: 229-233.
20. Stephenson DJ, Bezman L, Raymond GV. Acute presentation of childhood adrenoleukodystrophy. Neuropediatrics 2000; 31: 293-297.
21. Stradomska TJ, Tylki-Szymanska A. Decreasing serum VLCFA levels in ageing X-ALD female carriers. J Inherit Metab Dis 2001; 24: 851-857.
22. Stradomska TJ, Tylki-Szymanska A. Examination of very long chain fatty acids in diagnosis of X-linked adrenoleukodystrophy. Pediatr Pol 1996; 71: 197-201.
23. Takemoto Y, Suzuki Y, Tamakoshi A, Onodera O, Tsuji S, Hashimoto T, Shimozawa N, Orii T, Kondo N. Epidemiology of X-linked adrenoleukodystrophy in Japan. J Hum Genet 2002; 47: 590-593.
24. Tobimatsu S, Fukui R, Kato M, Kobayashi T, Kuroiwa Y. Multimodality evoked potentials in patients and carriers with adrenoleukodystrophy and adrenomyeloneuropathy. Electroencephalogr Clin Neurophysiol 1985; 62: 18-24.
25. van Geel BM, Assies J, Wanders RJ, Barth PG. X-linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy. J Neurol Neurosurg Psychiatry 1997; 63: 4-14.
26. Zgorzalewicz M. Endogenous and exogenous evoked potentials in the most common neurologic syndromes during development. Przegl Lek 2001; 58 Suppl 1: 16-21.